4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-002677
Options or other derivatives
- Chief Financial Officer acquired 841,632 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rawcliffe Adrian Chief Financial Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +687,984 | 687,984 | D | ||
| Rawcliffe Adrian Chief Financial Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +153,648 | 153,648 | D | ||
Loading xslF345X03/a4.xml…